Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate personalised treatment for patients.
Sapio Sciences, the science-aware lab informatics platform, has announced that Schrödinger has adopted the Sapio Platform to improve data management, enhance lab efficiency, and accelerate the discovery of novel molecules.
A cobot solution from FANUC and system integrator SKDK is alleviating health and safety issues at Takeda Pharmaceutical Company by working collaboratively with human employees to pack and stack packets of tablets onto pallets.
Tecan has announced the unveiling of Veya, a transformative liquid handling platform designed to bring efficiency, precision and compliance to laboratories of all sizes.
Absci Corporation and Owkin have announced a partnership bringing together two leading AI platforms to rapidly discover and design novel therapeutics for patients.
Mytos has entered into a manufacturing collaboration with Aspen Neuroscience to automate the manufacturing of autologous dopaminergic neuronal precursor cells (DANPCs) for ANPD001, Aspen’s investigational cell therapy program for Parkinson’s disease.
Michael Burkhard and Amr Eltablawi, Hexagon Asset Lifecycle Intelligence, delve into the top trends shaping pharmaceutical and life sciences operations in 2025.
Owkin has launched its latest report, State of the Nation: Opportunities and Challenges for Digital Pathology and AI Solutions, exploring the evolving landscape of digital pathology and AI in healthcare in the UK.
ArisGlobal’s director of product management’s Agnes Cwienczek, reports on AI-boosted regulatory process automation and other top-level findings from a new Censuswide survey of senior life sciences regulatory professionals.
Beckman Coulter Life Sciences, a company of Danaher Corporation, launches the Cydem VT Automated Clone Screening System, a high-throughput microbioreactor platform for automated top clone screening.
A new report commissioned by LogiPharma, has revealed the growing impact of artificial intelligence (AI) and machine learning (ML) on pharmaceutical supply chains, highlighting AI’s shift from a “nice-to-have” to a strategic necessity.
